Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Willmann

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Cancers|September 9, 2023
Deep-Learning-Based Dose Predictor for Glioblastoma-Assessing the Sensitivity and Robustness for Dose Awareness in ContouringRobert Poel, Amith J Kamath, Jonas Willmann, et al.
Physics and Imaging in Radiation Oncology|June 15, 2026
Transformer-based cardiac substructure segmentation from contrast and non-contrast computed tomography for radiotherapy planningAneesh Rangnekar, Nikhil Mankuzhy, Jonas Willmann, et al.
JCO Global Oncology|April 16, 2025
Cancer Care in Jordan: Multidisciplinary Solutions Needed for Complex DisparitiesAli Aljassabi, Tarek Zieneldien, Janice Kim, et al.
Physics and Imaging in Radiation Oncology|January 6, 2026
A dual-layer quality assurance approach leveraging dose prediction for efficient review of automated contours of organs at risk in the brain in radiotherapyRobert Poel, Amith Kamath, Ekin Ermiş, et al.
Clinical and Translational Radiation Oncology|May 2, 2022
Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of lifeSebastian M Christ, Markus Schettle, Jonas Willmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 20, 2020
Development of staffing, workload and infrastructure in member departments of the European Organisation for Research and Treatment of Cancer (EORTC) radiation oncology groupJonas Willmann, Philip Poortmans, Angelo Fillipo Monti, et al.
JAMA Oncology|September 4, 2025
Current Controversies and Challenges in Non-Oncogene-Addicted Synchronous Oligometastatic Non-Small Cell Lung Cancer: A ReviewMandy Jongbloed, Martina Bortolot, Jonas Willmann, et al.
Translational Lung Cancer Research|September 15, 2025
Adjuvant radiotherapy in the era of new peri-operative systemic treatments for surgically resected non-small-cell lung cancer: where do we stand?Francesca R Ogliari, Jarno W J Huijs, Mandy Jongbloed, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2022
Distant Metastasis Velocity as a Novel Prognostic Score for Overall Survival After Disease Progression Following Stereotactic Body Radiation Therapy for Oligometastatic DiseaseJonas Willmann, Eugenia Vlaskou Badra, Selma Adilovic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2023
Repeat stereotactic body radiotherapy for oligometastatic diseaseJonas Willmann, Selma Adilovic, Eugenia Vlaskou Badra, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Cancers|September 9, 2023
Deep-Learning-Based Dose Predictor for Glioblastoma-Assessing the Sensitivity and Robustness for Dose Awareness in ContouringRobert Poel, Amith J Kamath, Jonas Willmann, et al.
Physics and Imaging in Radiation Oncology|June 15, 2026
Transformer-based cardiac substructure segmentation from contrast and non-contrast computed tomography for radiotherapy planningAneesh Rangnekar, Nikhil Mankuzhy, Jonas Willmann, et al.
JCO Global Oncology|April 16, 2025
Cancer Care in Jordan: Multidisciplinary Solutions Needed for Complex DisparitiesAli Aljassabi, Tarek Zieneldien, Janice Kim, et al.
Physics and Imaging in Radiation Oncology|January 6, 2026
A dual-layer quality assurance approach leveraging dose prediction for efficient review of automated contours of organs at risk in the brain in radiotherapyRobert Poel, Amith Kamath, Ekin Ermiş, et al.
Clinical and Translational Radiation Oncology|May 2, 2022
Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of lifeSebastian M Christ, Markus Schettle, Jonas Willmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 20, 2020
Development of staffing, workload and infrastructure in member departments of the European Organisation for Research and Treatment of Cancer (EORTC) radiation oncology groupJonas Willmann, Philip Poortmans, Angelo Fillipo Monti, et al.
JAMA Oncology|September 4, 2025
Current Controversies and Challenges in Non-Oncogene-Addicted Synchronous Oligometastatic Non-Small Cell Lung Cancer: A ReviewMandy Jongbloed, Martina Bortolot, Jonas Willmann, et al.
Translational Lung Cancer Research|September 15, 2025
Adjuvant radiotherapy in the era of new peri-operative systemic treatments for surgically resected non-small-cell lung cancer: where do we stand?Francesca R Ogliari, Jarno W J Huijs, Mandy Jongbloed, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2022
Distant Metastasis Velocity as a Novel Prognostic Score for Overall Survival After Disease Progression Following Stereotactic Body Radiation Therapy for Oligometastatic DiseaseJonas Willmann, Eugenia Vlaskou Badra, Selma Adilovic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2023
Repeat stereotactic body radiotherapy for oligometastatic diseaseJonas Willmann, Selma Adilovic, Eugenia Vlaskou Badra, et al.
Pageof 9